Detection of N‐acetyl methionine in human and murine brain and neuronal and glial derived cell lines

J. Neurochem. (2011) 118, 187–194. Despite the fact that N‐acetyl methionine (NAM) supplementation has long been reported as a bioavailable source of methionine in humans, and known to reduce liver toxicity after acetaminophen overdose, its cellular endogenous presence has never been investigated. W...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 118; no. 2; pp. 187 - 194
Main Authors Smith, Tara, Ghandour, M. Said, Wood, Paul L.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.07.2011
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:J. Neurochem. (2011) 118, 187–194. Despite the fact that N‐acetyl methionine (NAM) supplementation has long been reported as a bioavailable source of methionine in humans, and known to reduce liver toxicity after acetaminophen overdose, its cellular endogenous presence has never been investigated. We demonstrate for the first time that NAM is present in both human and mouse tissues and cells in culture. A wide variety of cultured cells, including a number of brain derived cell types, as well as mouse and human brain tissue all have clearly detectable levels of NAM. Methionine is rapidly acetylated to form NAM in cultured human oligodendroglioma cells with an initial rate of 0.44 ± 0.064 atom percent excess per minute. The presence of measurable quantities of NAM in brain cells in combination with its rapid formation point to a potential physiological role for N‐acetylated methionine in the brain. Aminoacylase 1 is responsible for metabolism of NAM to methionine and acetate. Deficiencies in aminoacylase 1 have been linked to a variety of neurological disorders; however, it is unclear whether and how the brain is affected by this defect. The reported presence of NAM in the human brain may provide an invaluable key to discovering the link between aminoacylase 1 mutations and neurological problems.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-2
content type line 23
ISSN:0022-3042
1471-4159
1471-4159
DOI:10.1111/j.1471-4159.2011.07305.x